Lite Strategy, Inc. (LON:0JW9)
London · Delayed Price · Currency is GBP · Price in USD 1.150
+0.048 (4.36%)
Feb 12, 2026, 2:31 PM GMT
Lite Strategy Company Description
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer.
The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025.
Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.
Lite Strategy, Inc.
| Country | United States |
| Founded | 2000 |
| Industry | Medical - Pharmaceuticals |
| Sector | Healthcare |
| Employees | 4 |
| CEO | Justin File |
Contact Details
Address: 9920 Pacific Heights Blvd. San Diego, California 92121 United States | |
| Phone | 858 369 7100 |
| Website | litestrategy.com |
Stock Details
| Ticker Symbol | 0JW9 |
| Exchange | London Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| ISIN Number | US55279B3015 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Justin J. File CPA | Chief Executive Officer, Chief Financial Officer, Director and Corporate Secretary |
| Anne Frese | Chief People Officer |
| Dr. Robert D. Mass M.D. | Strategic Advisor |